Stockreport

Pathos AI Completes Acquisition of Rain Oncology

Rain Oncology Inc.  (RAIN) 
PDF Rain Stockholders to Receive $1.16 Per Share in Cash Plus Contingent Value Rights CHICAGO--(BUSINESS WIRE)--Pathos AI, Inc. (“Pathos”) today announced that it has, th [Read more]